Etiologies of Acute Liver Failure

ABSTRACT

Acute liver failure is present when any type of rapid-onset liver insult results in a common systemic pathophysiologic picture: altered mental status, vasodilation, renal and pulmonary failure, frequent infection, and poor outcome without transplantation. Identifying which of the many different causes is a first step in understanding prognosis and options for treatment. However, identifying the correct cause can be difficult and sometimes impossible. Any discussion of etiologies must take a historical perspective; there have been several evolving trends nationally and internationally over the past three decades. Etiologies also vary worldwide with considerable differences apparent between Western countries and the developing world. In Europe and North America a large proportion of cases are due to acetaminophen and to idiosyncratic drug reactions, whereas reports from emerging countries in Asia and Africa feature viral illnesses, particularly hepatitis B and E. Determining etiology is important for two reasons: specific antidotes or therapies may be indicated once the diagnosis is known, and knowing the cause provides a reasonably valid guide to predicting outcome.

Acute liver failure - acetaminophen - hepatitis - drug-induced liver injury - Budd-Chiari syndrome - Wilson's disease

REFERENCES

• 1 Ritt D J, Whelan G, Werner D J, Eigenbrodt E H, Schenker S, Combes B. Acute hepatic necrosis with stupor or coma: an analysis of thirty-one patients.  Medicine. 1969;  48 151-172
• 2 Rakela J, Mosley J W, Edwards V M. and the Acute Hepatic Failure Study Group . A double-blinded, randomized trial of hydrocortisone in acute hepatic failure.  Dig Dis Sci. 1991;  36 1223-1228
• 3 Schiødt F V, Atillasoy E, Shakil A O et al.. Etiology and outcome for 295 patients with acute liver failure in the United States.  Liver Transpl Surg. 1999;  5 29-34
• 4 Shakil A O, Kramer D, Mazariegos G V et al.. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria.  Liver Transpl. 2000;  6 163-169
• 5 Ostapowicz G, Fontana R J, Schiødt F V et al.. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.  Ann Intern Med. 2002;  137 947-954
• 6 Escorsell A, Mas A, de la Mata M. and the Spanish Group for the Study of Acute Liver Failure . Acute liver failure in Spain: analysis of 267 cases.  Liver Transpl. 2007;  13 1389-1395
• 7 Schiødt F V, Lee W M. Drug-induced liver injury. In: Yamada Atlas of Gastroenterology and Hepatology. 4th ed. Philadelphia; Lippincott Williams and Wilkins 2008: 637-640
• 8 Acharya S K, Dasarathy S, Kumer T L et al.. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome.  Hepatology. 1996;  23 1448-1455
• 9 Jilani N, Das B C, Husain S A et al.. Hepatitis E virus infection and fulminant hepatic failure during pregnancy.  J Gastroenterol Hepatol. 2007;  22 676-682
• 10 Proceedings of the Food and Drug Administration Nonprescription Drugs Advisory Committee meeting; September 19, 2002 Silver Spring, MD; Testimony of Parivash Nourjah, Ph.D. http://Available at: www.fda.gov/ohrms/dockets/ac/cder02.htm#NonprescriptionDrugs Accessed March 31, 2008
• 11 Larson A M, Polson J, Fontana R J and the Acute Liver Failure Study Group et al.. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.  Hepatology. 2005;  42 1364-1372
• 12 http://www.drugtopics.com/drugtopics/data/articlestandard/drugtopics/092007/407652/article.pdf Accessed March 31, 2008
• 13 Bower W A, Johns M, Margolis H S, Williams I T, Bell B P. Population-based surveillance for acute liver failure.  Am J Gastroenterol. 2007;  102 2459-2463
• 14 Davern II T J, James L P, Hinson J A and the Acute Liver Failure Study Group et al.. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.  Gastroenterology. 2006;  130 687-694
• 15 James L P, Alonso E M, Hynan L S and the Pediatric Acute Liver Failure Study Group et al.. Detection of acetaminophen-protein adducts in children with acute liver failure of indeterminate cause.  Pediatrics. 2006;  118 e676-e681
• 16 Bertholf R L, Johannsen L M, Bazooband A, Mansouri V. False-positive acetaminophen results in a hyperbilirubinemic patient.  Clin Chem. 2003;  49 695-698
• 17 Beuhler M C, Curry S C. False positive acetaminophen levels associated with hyperbilirubinemia.  Clin Toxicol (Phila). 2005;  43 167-170 , erratum 325
• 18 Hawton K, Townsend E, Deeks J et al.. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study.  BMJ. 2001;  322 1203-1207
• 19 Sheen C L, Dillon J F, Bateman D N et al.. Paracetamol pack size restriction: the impact on paracetamol poisoning and over-the-counter supply of paracetamol, aspirin and ibuprofen.  Pharmacoepidemiol Drug Saf. 2002;  11 329-331
• 20 Lee W M. Acetaminophen toxicity: changing perceptions of a social/medical issue.  Hepatology. 2007;  46 966-970
• 21 Department of Health and Human Services .Food and Drug Administration 21 CFR Parts 201 and 343 [Docket No. 1977N-0094L] RIN 0910-AF36. Internal Analgesic, Antipyretic, and Anti-rheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling. Available at: http://www.accessdata.fda.gov/scripts/oc/ohrms/frbydocket.cfm Accessed March 31, 2008
• 22 Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury.  Semin Liver Dis. 2002;  22 137-144
• 23 Kaplowitz N. Idiosyncratic drug hepatotoxicity.  Nat Rev Drug Discov. 2005;  4 489-499
• 24 Chang C Y, Schiano T D. Review article: drug hepatotoxicity.  Aliment Pharmacol Ther. 2007;  25 1135-1151
• 25 Navarro V J, Senior J R. Drug-related hepatotoxicity.  N Engl J Med. 2006;  354 731-739
• 26 Fuchs S, Simon Z, Brezis M. Fatal hepatic failure associated with ciprofloxacin.  Lancet. 1994;  343 738-739
• 27 Clay K D, Hanson J S, Pope S D, Rissmiller R W, Purdum III P P, Banks P M. Brief communication: severe hepatotoxicity of telithromycin-three case reports and literature review.  Ann Intern Med. 2006;  144 415-420
• 28 Taylor R M, Davern T J, Munoz S et al.. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes.  Hepatology. 2006;  44 1589-1597
• 29 Sookoian S. Liver disease during pregnancy: acute viral hepatitis.  Ann Hepatol. 2006;  5 231-236
• 30 Ikeda K, Shiga Y, Takahashi A et al.. Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment.  Leuk Lymphoma. 2006;  47 155-157
• 31 Ozasa A, Tanaka Y, Orito E et al.. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.  Hepatology. 2006;  44 326-334
• 32 Yeo W, Chan P K, Zhong S et al.. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.  J Med Virol. 2000;  62 299-307
• 33 Tillmann H L, Hadem J, Leifeld L et al.. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.  J Viral Hepat. 2006;  13 256-263
• 34 Reshef R, Sbeit W, Tur-Kaspa R. Lamivudine in the treatment of acute hepatitis B.  N Engl J Med. 2000;  343 1123-1124
• 35 Kumar M, Satapathy S, Monga R et al.. A randomized controlled trial of lamivudine to treat acute hepatitis B.  Hepatology. 2007;  45 97-101
• 36 Seremba E, Sanders C, Jain M and the Acute Liver Failure Study Group et al. Use of nucleoside analogues in HBV-related acute liver failure.  Hepatology. 2007;  46(suppl) 276A
• 37 Teo E K, Ostapowicz G A, Hussain M, Lee W M, Fontana R J, Lok A SF. and US Acute Liver Failure Study Group . Hepatitis B infection in patients with acute liver failure in the United States.  Hepatology. 2001;  33 972-976
• 38 Umemura T, Tanaka E, Ostapowicz G et al.. Investigation of SEN virus infection in patients with cryptogenic acute liver failure, aplastic anemia and acute and chronic non-A-E hepatitis.  J Infect Dis. 2003;  188 1545-1552
• 39 Lee W M, Brown K E, Young N S and the Acute Liver Failure Study Group et al.. Brief report: no evidence for hepatitis E or parvovirus B19 infection in patients with acute liver failure.  Dig Dis Sci. 2006;  51 1712-1715
• 40 Ichai P, Afonso A M, Sebagh M et al.. Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis.  Liver Transpl. 2005;  11 1550-1555
• 41 Levitsky J, Thadareddy A, Lakeman F A et al.. Herpes simplex virus in acute liver failure.  Gastroenterology. 2007;  132(suppl 2) A-752
• 42 Nakazawa H, Ito T, Makashima H et al.. Adenovirus fulminant hepatic failure: disseminated adenoviral disease after unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia.  Intern Med. 2006;  45 975-980
• 43 Ferrari R, Pappas G, Agostinelli D et al.. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the “acute” type.  QJM. 2004;  97 407-412
• 44 Kessler W R, Cummings O W, Eckert G, Chalasani N, Lumeng L, Kwo P Y. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.  Clin Gastroenterol Hepatol. 2004;  2 625-631
• 45 Sharp J R, Ishak K G, Zimmerman H J. Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin.  Ann Intern Med. 1980;  92 14-19
• 46 Pohle T, Menzel J, Domschke W. Minocycline and fulminant hepatic failure necessitating liver transplantation.  Am J Gastroenterol. 2000;  95 560-561
• 47 Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline-induced autoimmune hepatitis and systemic lupus erythematous-like syndrome.  BMJ. 1996;  312 169-172
• 48 Misdraji J, Thiim M, Graeme-Cook F M. Autoimmune hepatitis with centrilobular necrosis.  Am J Surg Pathol. 2004;  28 471-478
• 49 Menon K VN, Shah V, Kamath P. The Budd-Chiari syndrome.  N Engl J Med. 2004;  350 578-585
• 50 Kuo P C, Johnson L B, Hastings G et al.. Fulminant hepatic failure from the Budd-Chiari syndrome: a bridge to transplantation with transjugular intrahepatic portosystemic shunt.  Transplantation. 1996;  62 294-296
• 51 Ryu R K, Durham J D, Krysl J et al.. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome.  J Vasc Interv Radiol. 1999;  10 799-805
• 52 Shrestha R, Durham J, Wachs M et al.. Use of transjugular intrahepatic portosystemic shunt as a bridge to transplantation in fulminant hepatic failure due to Budd-Chiari syndrome.  Am J Gastroenterol. 1997;  92 2304-2306
• 53 Ockner S A, Brunt E M, Cohn S M, Krul E S, Hanto D W, Peters M G. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation.  Hepatology. 1990;  11 59-64
• 54 Halim A, Kanayama N, El Maradny E et al.. A study in cases of HELLP syndrome (hemolysis, elevated liver enzymes and low platelets) and acute fatty liver of pregnancy.  Gynecol Obstet Invest. 1996;  41 106-112
• 55 Lindheimer M D. Unraveling the mysteries of preeclampsia.  Am J Obstet Gynecol. 2005;  193 3-4
• 56 Levine R J, Maynard S E, Qian C et al.. Circulating angiogenic factors and the risk of preeclampsia.  N Engl J Med. 2004;  350 672-683
• 57 Bacq Y. Acute fatty liver of pregnancy.  Semin Perinatol. 1998;  22 134-140
• 58 Shaver W A, Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease.  Hepatology. 1986;  6 859-863
• 59 Berman D H, Leventhal R I, Gavaler J S, Cadoff E M, Van Thiel D H. Clinical differentiation of fulminant wilsonian hepatitis from other causes of hepatic failure.  Gastroenterology. 1991;  100 1129-1134
• 60 Roberts E A, Schilsky M L. A practice guideline on Wilson disease.  Hepatology. 2003;  37 1475-1492
• 61 Sallie R, Katsiyiannakis L, Baldwin D et al.. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure.  Hepatology. 1992;  16 1206-1211
• 62 Berman D H, Leventhal R I, Gavaler J S, Cadoff E M, Van Thiel D H. Clinical differentiation of fulminant wilsonian hepatitis from other causes of hepatic failure.  Gastroenterology. 1991;  100 1129-1134
• 63 Steindl P, Ferenci P, Dienes H P et al.. Wilson's disease in patients presenting with liver disease: a diagnostic challenge.  Gastroenterology. 1997;  113 212-218
• 64 Jhang J S, Schilsky M L, Lefkowitch J H, Schwartz J. Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease.  J Clin Apher. 2007;  22 10-14
• 65 Asfaha S, Almansori M, Qarni U, Gutfreund K S. Plasmapheresis for hemolytic crisis and impending acute liver failure in Wilson disease.  J Clin Apher. 2007;  22 295-298
• 66 Rowbotham D, Wendon J, Williams R. Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases.  Gut. 1998;  42 576-580
• 67 Agarwal K, Jones D E, Burt A D, Hudson M, James O F. Metastatic breast carcinoma presenting as acute liver failure and portal hypertension.  Am J Gastroenterol. 2002;  97 750-751
• 68 Rubio S, Barbero-Villares A, Reina T, Nieto S, Mendoza J, García-Buey L. Rapidly-progressive liver failure secondary to melanoma infiltration.  Gastroenterol Hepatol. 2005;  28 619-621
• 69 Bhat Y M, Krasinskas A, Craig F E, Shaw-Stiffel T A. Acute liver failure as an initial manifestation of an infiltrative hematolymphoid malignancy.  Dig Dis Sci. 2006;  51 63-67
• 70 Cameron A M, Truty J, Truell J et al.. Fulminant hepatic failure from primary hepatic lymphoma: successful treatment with orthotopic liver transplantation and chemotherapy.  Transplantation. 2005;  80 993-996
• 71 Garcin J M, Bronstein J A, Cremades S, Courbin P, Cointet F. Acute liver failure is frequent during heat stroke.  World J Gastroenterol. 2008;  14 158-159
• 72 Hadad E, Ben-Ari Z, Heled Y, Moran D S, Shani Y, Epstein Y. Liver transplantation in exertional heat stroke: a medical dilemma.  Intensive Care Med. 2004;  30 1474-1478
• 73 Broessner G, Beer R, Franz G et al.. Case report: severe heat stroke with multiple organ dysfunction-a novel intravascular treatment approach.  Crit Care. 2005;  9 R498-R501
• 74 Berger J, Hart J, Millis M, Baker A L. Fulminant hepatic failure from heat stroke requiring liver transplantation.  J Clin Gastroenterol. 2000;  30 429-431
• 75 Polson J, Lee W M. AASLD position paper: acute liver failure.  Hepatology. 2005;  41 1179-1197
• 76 Bernal W, Ma Y, Smith H M, Portmann B, Wendon J, Vergani D. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study.  J Hepatol. 2007;  47 664-670
• 77 Ichai P, Duclos-Vallée J C, Guettier C et al.. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.  Liver Transpl. 2007;  13 996-1003
• 78 Czaja A J. Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation.  Liver Transpl. 2007;  13 953-955
• 79 Rubio-Tapia A, Murray J A. The liver in celiac disease.  Hepatology. 2007;  46 1650-1658
• 80 Ojetti V, Fini L, Zileri Dal Verme L, Migneco A, Pola P, Gasbarrini A. Acute cryptogenic liver failure in an untreated coeliac patient: a case report.  Eur J Gastroenterol Hepatol. 2005;  17 1119-1121
• 81 Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort.  Arch Intern Med. 2003;  163 1566-1572
• 82 Abdo A, Meddings J, Swain M. Liver abnormalities in celiac disease.  Clin Gastroenterol Hepatol. 2004;  2 107-112